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ABSTRACT OF THESIS 
A COMPARISON OF BODY COMPOSITION ESTIMATES 
BETWEEN THE NORLAND DXA, THE IDXA, AND THE BODPOD®
IN OVERWEIGHT TO OBESE ADULTS  
Background: Body composition measures include fat mass (FM), fat free mass (FFM), 
and percent body fat (%BF), which are markers of health status and disease risk. 
Accurate body composition assessment is needed to evaluate an individual’s health and 
the efficacy of treatment strategies. Objective: Compare body composition estimates 
obtained from the Norland DXA, BodPod®, and iDXA before and after a 12-week 
exercise intervention. Subjects/setting: Overweight to obese (BMI 25–35 kg/m2) 
sedentary men and women (n=30) aged 18 to 40 years were recruited from central KY. 
Main outcome measure: Agreement in FM, FFM, and %BF between Norland DXA, 
iDXA, and BodPod®. Statistical analysis: Bland Altman plots evaluated mean bias and 
limits of agreement between iDXA vs Norland DXA, BodPod® vs Norland, and 
BodPod® vs iDXA. T-tests determined if each mean bias was different from zero. 
Results: Compared to the iDXA, Norland DXA overestimated BF% and FM at baseline 
and post intervention (P<0.01), without differences in FFM (P>0.05). The BodPod® 
underestimated BF% and FM and overestimated FFM compared to both DXA machines 
(all P<0.01). Conclusion: The Norland and iDXA produce different measures of FM but 
similar measures of FFM. As well, the BodPod® measures FM and FFM differently than 
either DXA machine. 
KEYWORDS: DXA, body composition, BodPod®, Norland, iDXA 
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Chapter One: Introduction 
Background 
Over 70% of the US adult population are overweight (BMI 25-29.9) or obese 
(BMI>30) [1, 2]. The overweight or obese phenotype is characterized by excess body fat 
stores, which are positively associated with metabolic conditions and cardiovascular 
disease [3]. Specifically, excess visceral adipose depots are far more problematic than 
subcutaneous depots, pre-disposing individuals to health complications such as heart 
disease and diabetes [4]. Accurate body composition assessment is therefore 
important, not only in assessing health status, but also in evaluating efficacy of 
interventions and treatment strategies [5, 6]. 
 In research and clinical settings there are a variety of methods used to assess 
body composition. Some examples include dual-energy x-ray absorptiometry (DXA), 
bioelectrical impedance analysis (BIA), hydrostatic weighing (underwater weighing), air 
displacement plethysmography (ADP), anthropometry, and body mass index (BMI). 
These methods vary in accuracy (the closeness of a measured value to a standard or 
known value) and precision (the degree to which repeated measurements of the same 
variable give the same value) and provide different information [7]. The only way to 
100% accurately assess body composition is through cadaver analysis. Therefore, new 
technology is constantly being developed to assess body composition in living 
individuals with DXA currently the most trusted technology.  
The GE Lunar iDXA is the most trusted and well-researched DXA model. The 
precision level of the iDXA is excellent (<1.08%CV) between measurements within an 
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individual [8]. Norland at Swissray claims to have most versatile DXA on the market, the 
Norland Elite, which can scan individuals up to 625 lbs, 54” cm wide, and 7’6” tall [9]. 
Due to technological advances of DXA scanners and the rise of new manufacturers, 
such as Norland at Swissray, it has become important to compare body composition 
measurements between machines [10]. 
Restraints of the DXA machine include cost and the requirement for a trained 
operator. Although DXA machines use x-ray technology, the amount of radiation is 
small (0.04 to 0.86 mrem, equivalent to between 1 and 10% of a chest radiograph), and 
safe for most people, although this limits its use among individuals with pacemakers or 
other medical implants [11]. DXA should also not be performed on pregnant females 
due to the unknown effects of radiation on the developing fetus [12]. ADP does not have 
these restraints and is therefore considered a more practical alternative to DXA. The 
most common ADP is Cosmed’s BodPod®, which requires only minimal training and 
has been demonstrated to have a high degree of accuracy compared to a 4-
Compartment (4C) model (R2 = 0.93) [13, 14]. Since measurements from the DXA are 
highly accurate and reproducible [11], many other methods, including ADP, are 
validated against DXA. However, conflicting findings have been reported regarding 
agreement of body composition measurements between DXA and BodPod® [5, 15]. 
Agreement between estimates from different DXA manufacturers is also uncertain [16]. 
Further, while the precision of DXA makes it useful for monitoring changes in body 
composition in longitudinal studies [8, 17], different body composition measurement 
tools may over-, or underestimate changes in fat and lean mass after weight loss [18].  
 
 
 3  
Problem Statement 
 
 A limitation of body composition assessment technology is the lack of agreement 
across methodologies. Due to different beam technology, scan speed, and software, 
different DXA machines are not always in agreement [16]. ADP may also not be 
agreeable with DXA due to the difference in how body composition is derived. ADP 
calculates body density and uses a density formula to calculate fat and lean mass, 
whereas DXA uses x-ray bean technology to quantify bone, fat-free, and fat mass. 
Understanding differences is critically important when interpreting epidemiological and 
clinical studies where different brands of DXA machines or different methodologies have 
been used [19]. Limited research exists examining the differences between the Norland 
DXA, the iDXA, and the BodPod®. In addition, differences in accuracy and precision 
between machines during weight loss is not well studied. The present study aimed to fill 
these gaps.  
 
Research Questions 
 
1. Are fat and lean mass estimates obtained using the BodPod® and Norland DXA in 
agreement with the estimates obtained using the hospital grade GE iDXA in an 
overweight to obese adult population? 
 
2. Are discrepancies in assessments of fat and lean mass between the iDXA, BodPod® 
and Norland DXA similarly present before and after a 12-week exercise intervention? 
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Hypothesis 
 
1. Fat and lean mass estimates obtained using the Norland DXA will be in agreement 
with the values obtained from the iDXA while the BodPod® will underestimate fat mass 
and overestimate lean mass estimates in overweight to obese adults compared to the 
iDXA.  
 
2. Differences in fat and lean mass estimates between the Norland DXA, iDXA, and 
BodPod® will be similar before and after longitudinal changes in fat and lean mass.  
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Chapter Two: Literature Review 
Introduction 
 
As of 2017, 38% of adult Americans are considered to be obese (Body Mass 
Index (BMI) ≥ 30) and an additional 33% are overweight (BMI = 25-29.9) [20]. 
Overweight and obesity refer to excess fat tissue in the body, which is linked to an 
increased risk for certain health complications such as cardiovascular disease and 
diabetes [21]. BMI is correlated with adiposity at the population level [22]; however, this 
is not an accurate assessment of body composition at the individual level as BMI does 
not provide specific information on body fat distribution or account for lean body mass 
[21]. Therefore, BMI is best suited as a convenient index to predict clinical disease 
outcomes in large groups of people. In a time where the prevalence of overweight or 
obese individuals is continually rising, there is an increased need for accurate, cost 
effective, and minimally invasive body composition measurement (i.e. quantification of 
fat and lean mass) beyond what BMI can assess [23]. At the individual level, accurately 
assessing body composition, particularly fat mass (FM), is not only important for 
determining disease risk but also to evaluate treatment efficacy [5, 6]. There are a 
variety of common methods currently used in research and clinical settings, such as 
dual-energy absorptiometry (DXA), bioelectrical impedance analysis (BIA), hydrostatic 
weighing, air displacement plethysmography (ADP), and anthropometry. 
Due to the inconvenient nature of hydrostatic weighing and large variability in 
other measures, DXA and ADP are being heavily relied on to measure body 
composition [5]. DXA has traditionally been used for osteoporosis screening and 
assessment of fracture risk, but is also certified as tool for assessing fat and lean mass 
[6]. The fundamental principal of the DXA machine is the use of x-ray transmission at 
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high and low frequencies to differentiate between fat and lean tissue [24]. Although DXA 
is accepted as a precise measurement of body composition there are still restraints 
related to the method. These machines are very costly, a specialized training and 
certification is required to operate them, and different machines from different 
manufactures may not provide the same estimate. Different beam technology, scan 
speed, and software can all contribute to the lack of compatibility between machines 
[16]. The purpose of this review is to evaluate other methods of body composition 
assessment in comparison to the GE Lunar iDXA, the most well-researched DXA and 
widely used machine. Other methods include additional manufactures of DXA 
machines, and the BodPod®, which uses ADP as a less expensive and burdensome 
method.  
Measurement of Body Composition 
Although there is no true reference standard for the assessment of body fat, 
some methods are more accurate and precise than others. Assessments with the least 
amount of assumptions are the best methods, typically accomplished by combining 
measurements from different models. Methods such as DXA and BodPod® are both 2-
compartment (2C) models where body weight is divided into FM and fat free mass 
(FFM). This model does not address inter-individual variability of the FFM or FM 
composition, rather most models use the assumed densities of 1.1000 g/cm3 and 
0.9007 g/cm3 respectively. Brozek and colleagues determined these density 
assumptions in 1952 from 3 male cadavers [25]. The 3-compartment model separates 
FFM into total body water (TBW), fat free dry mass, and FM, thereby offering a better 
understanding of what the FFM compartment consists of. This model still assumes a 
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constant mineral to protein ratio in the dry FFM but does control for inter-individual 
variation in FFM hydration since TBW is measured, often by deuterium dilution (D2O) 
[13, 26].  
A 4-compartment (4C) model is presently the best reference method given the 
major measurements available. This model is theoretically more valid than the 3C 
because it controls for biological variability in both bone mineral and TBW by including 
actual measurements over the use of assumptions [26]. The 4C divides the FFM into 
measured water (via deuterium dilution (D2O)) and mineral mass (via DXA), leaving the 
only assumption in the composition of the remaining components of the FFM such as 
protein, tissue, glycogen, etc. [13]. Figure 1 below describes the differences between 
each of the models. 
Figure 1. Body Composition Esimate Models 
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Although the DXA and the BodPod® are both 2C models, the way they derive 
their body composition estimates are very different. The BodPod® uses ADP, which 
derives body density by using the relationship between pressure and volume. Thoracic 
gas volume is either predicted or measured in order to calculate a corrected body 
volume (corrected body volume= raw body volume – thoracic gas volume). Body density 
is then calculated as body mass (weight) divided by the corrected body volume. This 
procedure involves sitting in a chamber while the volume of air displaced is calculated 
by measuring the pressure differences between the chamber with the subject in it and 
an additional empty chamber [27]. Equations are used to calculate body fat % (BF%) 
based on body density approximations [5].  
As mentioned above, DXA utilizes x-ray beams to quantify FM, bone mineral 
content (BMC), and FFM. Although 2C models typically split the body into lean and fat 
compartments, the DXA is considered a 2C model because the measurement of areal 
bone mineral density (BMD) assumes that the body is split between bone mineral and 
soft tissue compartments (muscle, fat, skin, water) making it a non-traditional 2C model 
[24]. It can only directly assess bone density and FM. DXA uses two distinct x-ray 
photon energies to distinguish between bone and soft tissue. More photons are able to 
pass through soft tissue, that is, the x-ray beam is attenuated less than it is when it 
passes through bone. The amount of fat and fat free soft tissue is determined by the 
ratio of attenuation of the two photon energies at places in the body that do not contain 
any bone. FM, lean tissue mass, and bone mineral mass can be differentiated after the 
attenuation of the x-ray beam has been analyzed in regions with both soft tissue and 
bone and soft tissue only [24].  
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Measurement During Weight Loss 
Monitoring changes in body composition is important during weight loss 
programs or treatments where accurate assessment of FM and FFM would provide 
better individual feedback and program evaluation than changes in total body weight 
alone. Specifically, weight loss interventions should strive to avoid the loss of FFM, as 
this could subdue basal metabolic rate and lead to a post-dieting weight rebound [3], 
thus necessitating the accurate quantification of both and FFM and FM. Accurate body 
composition assessment over time is also important in the athletic population where 
unwanted changes in an athlete’s body composition could hinder athletic performance. 
For example, gymnasts require a low body fat percentage (%BF) in order to maximize 
their performance, as excess body fat would negatively affect their power to weight ratio 
and speed required in many events. Another example is in team sports where different 
positions often confer different goals and training programs, thus making it important to 
monitor changes and make recommendations on an individual basis. It is important for 
body composition assessment methodologies to be reliable in these cases. Reliability is 
defined as the reproducibility of the observed value when the measurement is repeated 
[28]. Reliability facilitates the ability to detect changes over time between measurements 
on the same individual [16].  
As detailed in Table 1, several studies have been conducted assessing the 
sensitivity to change between body composition assessment methodologies after a 
long-term weight loss intervention. Compared to a 4C model where BMC is assessed 
from DXA, body volume (from ADP) and total body water (D2O), DXA was found to 
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overestimate the change in FM and the %FM while anthropometry underestimated FM 
and %FM [3]. Therefore, body composition methods should not be applied 
interchangeably when assessing changes after a weight loss program [18].   
Significant bias between body composition estimates obtained by anthropometry, 
D2O, ADP, and DXA also exists. Bias is defined as the difference between the 
measured value and the true value of the parameter being assessed. D2O is used to 
derive body composition from the total body water volume (BWV) measure. BWV is 
multiplied by a hydration constant to yield FFM in kilograms and %BF can be calculated 
by subtracting FFM from total body weight. D2O overestimates FM by ADP when 
compared with the 4C model [3]. The bias between D2O and densitometry (under water 
weighing) when compared with the 4C model can be explained by the inaccurate 
assumption of the constant hydration of FFM [3]. All two-compartment models have a 
systematic error when used after weight loss because hydration status does not 
normalize. This is possibly due to a variety of reasons including malnutrition, 
extracellular water/intracellular water ratio of adipose tissue, a defect in hemo- and fluid 
regulation, cell shrinking, and/or an insulin-mediated sympathetic stimulation [29]. There 
is also bias between the 4C model and the DXA, explained by the greater tissue 
thickness at baseline, producing an overestimation of %FM. The more adipose tissue 
an individual has, the greater the FFM hydration [30] which may contribute to an 
additional bias of 5 percentage points [29]. These findings suggest 2C models such as 
DXA cannot be used to accurately assess changes in body composition with weight 
loss, as only the 4C model and MRI could be confidently used [3]. This raises the 
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question if the DXA can confidently be considered the “gold standard” body composition 
method.  
Verdich et al. found strong correlations between FM estimates by BIA and DXA 
at baseline when using two different brands (Lunar and Hologic) of DXA machines. 
Conversely, bias was found between methods with respect to FFM with BIA 
overestimating the loss of FFM and slightly underestimating the loss of FM compared to 
DXA after 10 weeks. Post-intervention the Lunar DXA and BIA’s assessment of FM 
change was correlated (r=0.57, P<0.001) while FFM was not. The Hologic DXA and 
BIA’s changes in both FM (r=0.40) and FFM (r=0.74) were correlated (P<0.001 for 
both). However, since the limits of agreement at the individual level for changes in FM 
were wide between DXA and BIA, these estimates should not be used interchangeably 
when assessing weight loss [31]. 
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Table 1. Summary of Research Realted to Body Composition Measurement 
During Weight Loss 
Source Study Design Methods 
Compared 
Study Population Primary Findings 
Minderico et 
al. [18] 
N = 48, 
Body 
composition 
measured at 
baseline and 
post 16 
month 
intervention  
DXA, BIA, & 
Anthropometry 
compared to 4C 
model 
Women, >24 years, 
Premenopausal, 
BMI > 24.9, 
participating in a 2-
year weight 
management 
program. 
DXA was found 
to overestimate 
the change in FM 
and the %FM 
while 
anthropometry 
underestimated 
FM and %FM 
Pourhassen 
et al. [3] 
N=83, Body 
composition 
measured 
based on net 
body weight 
changes from 
previous 
study (n=30 
weight loss, 
n=33= weight 
gain, n=20 
weight 
stable) 
Anthropometry, 
D2O, ADP & DXA 
Men & women, 
aged 21-58 years, 
BMI between 20.2 
and 46.8 
Significant bias 
between body 
composition data 
obtained by 
anthropometry, 
D2O, ADP, and 
DXA existed. 
Only the 4C 
model and MRI 
could be 
confidently used. 
Verdic et al. 
[31] 
N=771, Body 
composition 
measured 
before and 
after weight 
loss 
intervention 
BIA vs. DXA Obese Caucasian 
adults (580 women 
& 191 men) enrolled 
in a 10 week dietary 
intervention study 
No significant 
differences in FM 
changes 
regardless of 
which DXA 
machine was 
used after weight 
loss. Wide limits 
of agreement at 
the individual 
level for changes 
in FM. 
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DXA vs. BodPod® 
Since DXA machines are expensive and require specialized training to operate, 
many laboratories and service centers are turning to ADP. The most common device is 
Cosmed’s BodPod®. 
As described in Table 2, multiple studies have compared body composition 
estimates from BodPod® and DXA machines. Recent comparisons demonstrate the 
BodPod® overestimates BF% in the leaner subjects (up to 13.2 percentage points) and 
underestimates BF% in the heavier subjects (up to -8.51 percentage points). The 
differences are most pronounced in underweight individuals and may be explained by 
the assumptions that are essential in the calculation of BF% from direct measurements. 
ADP is a traditional 2C model, assuming the body has only two tissue types: lean mass 
and fat mass; when in reality fat-free mass includes of water, bone, muscle, 
vasculature, and connective tissue, thus ADP does not fully account for the degree of 
variance in FFM. DXA would theoretically be more accurate because it can determine 
BMD therefore eliminating one degree of variability [5].  
Ballard et al reported no differences between DXA and ADP for %BF (ADP = 
22.5 + 5.5%, DXA = 22.0 + 4.7%, means + SD) or FFM (ADP = 15.1 + 5.1 kg, DXA = 
15.1 + 4.5 kg) among athletes. There were also no differences between the DXA and 
ADP for BF% (ADP = 28.5 + 6.7%, DXA = 28.2 + 5.2%) or FFM (ADP = 45.9 + 5.7 kg, 
DXA = 44.9 + 5.1 kg) among non-athletes. These results indicate that ADP is reliable 
and valid in female college athletes and non-athletes when compared with the DXA and 
the researchers concluded it can be used as an acceptable measure to track body 
composition [15]. What is still unclear is how different DXA machines compare.  
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Table 2. Summary of Research Related to Body Composition Measurements from 
DXA and BodPod® 
Source Study Design Methods 
Compared 
Study Population Primary 
Findings 
Lowry et 
al. [5] 
N=64, Body 
composition 
estimates 
compared 
between 
machines 
within 6 hours 
of each other  
BodPod® & 
DXA (Lunar 
Prodigy – GE 
Healthcare) 
Individuals from all 
four BMI 
classifications 
N= 30, 
Underweight 
(BMI<18.5), N=15, 
Normal weight 
(18.5-24.99), N= 
19 
Overweight/Obese 
(BMI > 25) 
BodPod® 
overestimated 
BF% in leaner 
subjects and 
underestimated 
BF% in the 
heavier 
subjects. 
Ballard et 
al. [15] 
N=71, Body 
Composition 
Measurements 
compared 
between 
machines and 
groups  
BodPod® & 
DXA (Hologic 
QDR 4500) 
Division II female 
athletes & non-
athletes, aged 18-
21 
No differences 
between DXA 
and ADP for 
%BF in the 
athlete group. 
There were no 
differences 
between the 
DXA and ADP 
for BF% in the 
control group 
Differences in DXA Machines 
Four compartment models are the most accurate; however, they are incredibly 
complex, costly, time consuming and invasive. Therefore they cannot be used in 
settings where body composition is assessed frequently [32]. DXA is well-accepted as 
the best alternative demonstrating precision between measurements within an individual 
[8], and between different models of DXA [5]. Yet, due to recent technological advances 
of DXA scanners and the development of new models, it is important to compare data 
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between machines before the data is combined or used interchangeably for research or 
clinical application [10]. 
iDXA 
One improvement made in DXA technology is the shift from a pencil beam 
densitometer to a fan beam densitometer. Fan-beam systems use multiple detectors 
that allow for faster scan achievement and clearer image resolution [12]. Table 3 
describes current research on the different systems. For both genders, the iDXA (fan-
beam system) has reported a lower BMC than the Lunar DPX-L (pencil beam) and GE 
Lunar Prodigy (fan beam). The iDXA reported lower total, trunk and arm FFM for males 
compared to the other machines (P<0.03). For females the DPXL estimated greater 
FFM for total, trunk, and arms (P<0.001) but the iDXA estimated greater FFM in legs 
(p<0.01). For both men and women, mean values of FM and FFM for DPXL were 
greater than Prodigy (P<0.001) [33]. When looking at FM in females, all 3 machines 
were different for total, trunk, and legs (P<0.04) while DPXL and iDXA were greater than 
Prodigy in arm measurements (P<0.0004). For males, DPXL reported less total body, 
trunk, and leg FM compared to iDXA and Prodigy (P<0.001), and greater arm FM than 
Prodigy (P<0.0007). These findings suggest there are differences in total and regional 
FFM and FM on different DXA machines but overall FM and FFM are highly correlated 
between the three machines (r2 = 0.85 to 0.99). It is important to note that this study 
was conducted using the same brand of DXA (GE) [33].  
Morrison et al. compared two fan-beam systems and reported the iDXA provided 
lower estimates of total body BMD than the Prodigy (P<0.001). Measures of total body 
and trunk FM, FFM, and %BF were not different between the machines. In regional 
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analyses, estimates of FM and %BF were greater (P<0.01), and that of FFM was lower 
in the arms (P<0.0001). On the other hand, iDXA estimates of FFM were greater in the 
legs (P<0.001). Bland-Altman analyses demonstrated that significant bias occurred 
between iDXA and Prodigy for total body and regional BMD estimates. In addition, the 
iDXA estimated greater FM in total body, arms, and legs than the prodigy, which was 
mainly seen in subjects with greater body fat [10]. These small but significant 
differences between the iDXA and Prodigy indicate that additional measures must be 
taken to ensure the validity of data is maintained. One such measure may be the 
development of cross-calibration equations, which can be used to convert an estimate 
from one type of machine to an estimate from a different type of machine. This is 
especially important in longitudinal studies where data from different machines may be 
merged, when comparing outcomes across machines, or when interpreting 
epidemiological and clinical studies where two or more systems of different brands are 
used [10, 19, 33].  
Other DXA models 
Different commercial DXA machines may offer different soft tissue and BMC 
estimates [7]. The Hologic DXA has a switching pulse system that rapidly alternates the 
voltage of the x-ray generator, producing two beams of high and low energies. The 
attenuated x-rays are measured sequentially with a detector located on the scanning 
arm above the patient as they are passed through the subject. In the Lunar and Norland 
systems, a constant-potential x-ray generator produces x-rays and a k-edge filter 
separates the beam into high and low energy regions. These machines use an energy-
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discriminating detector to measure the attenuated x-rays that pass through the subject 
[7].  
Gillette-Guyonnet et al, (Table 3), reported total FM, %BF, and FFM were similar 
between the Hologic QDR-4500 and Lunar DPX-L DXA. On the other hand, whole body 
BMC values determined by the Lunar DXA were greater than the Hologic DXA (P=0.02), 
although these were still within Bland-Altman limits of agreement (95% confidence 
limits) [19]. Thus, these two DXA machine measurements may be used 
interchangeably, especially for FM and %BF.  
Importance of Intra-Instrument Validation 
The GE Lunar iDXA is the most widely used body composition assessment tool 
in research and clinical settings. As detailed in Table 3, multiple studies have tested the 
precision of the iDXA with coefficients of variations (%CV) reported at 1.08% for total 
body bone mineral content (TBBMC), 0.94% for FFM 0.90% for FM, 1.00% for total 
body lean (TBL, TBBMC + FFM), and 0.79% in BF in an obese population. In regards to 
fat distribution, precision was 1.44% for gynoid fat distribution and 1.64% for android fat 
distribution [8]. Others have demonstrated similarly precise measures of TBBMC 
(0.5%), FM (1.0%) and FFM (0.5%) in normal weight subjects [17]. The Lunar Prodigy 
DXA has also displayed excellent precision in normal weight adults with %CV of1.3% 
for TBBMC, 2.7% for %BF, 2.5% for BF, and 0.8% for TBL [34]. Therefore, both Prodigy 
and iDXA machines demonstrate excellent precision in adults regardless of weight 
status, making either Prodigy or iDXA appropriate in monitoring longitudinal changes, 
an important aspect of any valid assessment methodology.  
18  
Table 3. Summary of Research Related to Body Composition Measurements from 
Different DXA machines 
Source Study Design Methods Compared Study Population Primary Findings 
Hull et al. 2009 
[33] 
N=99, Body 
composition 
measurements were 
compared between 3 
DXA machines (one 
pencil beam & two fan 
beam systems) 
3 DXA machines: 
Lunar DPX-L, GE 
Lunar Prodigy, & GE 
Lunar iDXA 
Healthy multi-ethnic adults 
(47 males & 52 females), 
aged 18-81 years, BMI’s 
ranged normal to obese 
Differences in BMC, 
total and regional lean 
and FM on different 
DXA machines but 
overall good 
agreement between 
the three machines (r2 
= .85 to 0.99) 
Morrison et al, 
2016 [10] 
N=92, Body 
composition 
measurements 
compared between 
older & newer GE DXA 
machines 
GE-Lunar Prodigy 
DXA & GE-Lunar 
iDXA 
Healthy adults, aged 20-74 
yeas (56 females & 36 
males) 
Significant bias 
occurred between 
iDXA and Prodigy for 
total body and regional 
BMD estimates. iDXA 
overestimation bias 
existed for FM in total 
body, arms, and legs. 
Gillette-Guyonnet 
et al, 2003 [19] 
N=7, Body 
composition 
measurements 
compared between 
two different brands & 
type of DXA machines 
Hologic QDR-4500 
(Fan-beam) & Lunar 
DPX-L (pencil beam) 
Females between the ages 
of 40 & 57 years 
Agreement between 
the two DXA estimates 
of FM, %BF, fat free 
soft tissue mass, BMC 
and BMD was found. 
Carver, Cristou, 
& Andersen, 
2013 [8] 
N=65, Body 
composition 
measurements 
compared to evaluate 
precision of iDXA by 
conducting two 
consecutive scans 
iDXA vs. IDXA Severely obese adults (24 
males & 41 females); 
average BMI=49 
Precision was 1.08% 
TBBMC, 0.94% for 
FFM 0.90% TBF, 
1.00% TBL, 0.79% 
%TB. Precision was 
1.44% for gynoid fat 
distribution and 1.64% 
for android fat 
distribution. 
Rothney et al, 
2012 [17] 
N= 114, Body 
composition 
measurements 
compared to evaluate 
precision of iDXA by 
conducting two 
consecutive scans 
iDXA vs. iDXA Non-obese adults (47 
males & 67 females), aged 
22-60
Total body precision 
for BMC was 0.5%, 
1.0% for FM, and 
0.5% for lean mass. 
Precision error for 
regional body 
composition was less 
than 2.5% in all 
regions except for 
arms. 
Conclusion 
Body composition assessment is important for evaluating health and nutritional 
status, providing information body weight alone cannot. Accurate measurement of body 
composition is crucial for understanding the efficiency of weight loss interventions and 
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understanding how bones and tissues change during weight loss, aging, and wasting 
diseases [7]. DXA has become the primary method in a variety of settings but due to 
technological advances and differences between brands there can be variations in the 
measurements. There is strong consistent research regarding the iDXA; however, a 
lack of information exists on other manufactures such as the Norland DXA. It is also 
unclear how machines such as the Norland DXA and BodPod® measure body 
composition in a negative energy balance and how well these measurements agree to 
the “gold standard” iDXA.  
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Chapter Three: Methodology  
Research Design 
 The present study is a sub-analysis from a randomized controlled trial assessing 
longitudinal changes in energy compensation after a 12-week exercise intervention 
among overweight to obese adults. Subjects were randomly assigned to one of three 
exercise groups: sedentary control, 6 exercise sessions per week, or 2 exercise 
sessions per week. Body composition measurements were obtained at baseline and 
then again following the 12-week intervention (post). For the exercise treatments, 
subjects participated in aerobic exercise (treadmill, stationary bike, elliptical) to produce 
a 2000-3000-calorie per week energy expenditure. Exercise sessions were prescribed 
based on individual rates of energy expenditure (calorie/minute) at different heart rate 
zones. To verify treatment implementation, subjects wore a chest-strap heart rate 
monitor and sessions were recorded on a watch and downloaded each week to 
calculate energy expenditure of each session.  
 
Subjects 
 A total of 30 adults, (23 females and 7 males) between the ages of 18 and 40 
years were recruited throughout the greater Lexington metropolitan area and 
surrounding communities. The subjects had to be overweight to obese (BMI 25–35 
kg/m2), sedentary (not engaging in exercise) and not dieting to lose weight. Additional 
exclusion criteria included being pregnant or lactating, taking any medications that affect 
energy expenditure, tobacco use, major health issues such as cardiovascular, 
pulmonary, and metabolic diseases, or any medical condition that would be a 
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contraindication to safe exercise. All aspects of the study were approved by the 
University of Kentucky Institutional Review Board and registered with ClincialTrials.gov, 
identifier NCT03413826. 
Measurements 
Height and Weight 
Height and body weight were measured in the Nutrition Assessment Laboratory 
in the Department of Dietetics and Human Nutrition at the University of Kentucky during 
an initial screening visit to determine if subjects meet the BMI and other inclusion 
criteria. Body weight was measured with a Seca scale (Chino California) after voiding 
with subjects wearing scrubs or shorts and a t-shirt and no shoes. Height was measured 
with a stadiometer with standard anthropometric technique.  
DXA Measurements 
For each individual, body composition was measured using a GE Lunar iDXA 
machine (GE Lunar Inc., Madison, WI; software version 13.10, located at the University 
of Kentucky Albert B. Chandler Hospital) and a Norland Elite DXA machine (Norland at 
Swissray, Fort Atkinson, WI, located at the University of Kentucky Joe Craft Football 
Training Facility) within the same hour. Individuals did not eat or drink between the two 
scans. Absolute and relative measures of total body and regional soft tissue (fat, fat-free 
and mineral-free lean) masses were obtained from each DXA machine using 
standardized procedures. A total body scan was conducted with subjects lying supine 
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on the table and arms positioned to the side and palms flat on the table. Scans were 
completed using the standard mode, unless the software selected the thick scan mode. 
The iDXA scans were analyzed using GE Lunar enCORE Software (13.60.033) and 
scans of the Norland were analyzed using Illuminatus DXA Software (4.6.4). The 
machines were calibrated before each scanning session, using the GE Lunar calibration 
phantom and the Illumination calibration for the iDXA and Norland machines 
respectively. The same trained operators performed all of the DXA scans, one trained 
operator performed all the iDXA scans and another trained operator performed all the 
Norland scans.   
 
BodPod® Measurements 
 Body composition was also estimated via ADP using the BodPod® (COSMED, 
Inc BodPod®, Chicago, IL) in the fasted state within the same week as the DXA scans. 
In order to minimize potential error due to isothermal air trapped in clothing and hair, all 
subjects wore tight fitting athletic gear and swim caps. Thoracic gas volume was 
measured on all subjects according to manufactures recommendations. Outcomes 
included %BF, fat mass, and fat free mass. 
 
Statistical Analysis  
FM and FFM (kg), and %BF for each individual was compared between the three 
body composition assessment methods (iDXA, Norland DXA, and BodPod®). Bias for 
the Norland DXA compared to the iDXA was defined as: iDXA – Norland= Norlandbias. 
Bias for the BodPod® compared to the Norland and iDXA was defined as: Norland – 
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BodPod® = BodPod®biasNorland and iDXA – BodPod® = BodPod®biasiDXA.  Independent 
sample T-tests were used to determine if any of the bias measurements (Norlandbias, 
BodPod®biasNorland, BodPod®biasiDXA) were different from zero. A significant p value in this 
case would indicate a bias different from zero, which would confer a large discrepancy 
in measurements. These biases were calculated for baseline measurements and post-
intervention measurements of BF%, FM, and FFM. The mean difference between pre-
post change scores between each machine for BF%, FM, and FFM were also tested if 
different from 0 to determine if comparisons between machines differed before and after 
weight loss. Comparisons between two machines before and after weight loss (change 
scores) significantly different from 0 would indicate an inconsistency between machines 
when assessing longitudinal changes in body composition.  
Bland-Altman (B&A) plots were used to demonstrate the agreement between the 
Norland and iDXA, between the iDXA and BodPod®, and between Norland and 
BodPod®. Pre and post values for each measurement were included in each plot with 
upper and lower limits calculated as +/-1.96 SD. B&A plot analysis is a method to 
quantify agreement between two quantitative measurements by constructing limits of 
agreement. The statistical limits are calculated by using the mean and the standard 
deviations of the differences between two measurements, where upper limits of 
agreement are +1.96 SD from the mean and lower limits defined as -1.96 SD. The B&A 
plot analysis demonstrate where each individual value falls in relation to the agreement 
interval. The resulting graph is a scatter plot XY, where the Y-axis shows the difference 
between the two-paired measurements (bias) and the X-axis shows the average of 
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these measures [35]. All statistical analysis was carried out with R statistical software 
(3.5.1., 2018).  
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Chapter 4: Results 
The demographic characteristics of the subjects are listed in Table 4. Table 5 
displays the mean bias, the 95% limits of agreement (+1.96 SD), and corresponding p-
values. The Norland DXA overestimated BF% and FM at both baseline and post time 
points (before and after 12 week weight loss intervention) compared to the iDXA (all 
P<0.01). There were no significant differences between the Norland and iDXA for 
measures of FFM at baseline or post (P>0.05). The BodPod®, when compared to the 
iDXA and Norland, underestimated BF% and FM while overestimating FFM at both 
baseline and post (all P<0.01).  
Table 6 describes the change scores between the three machines. The change 
scores were calculated by subtracting the post measurements for each body 
composition parameter from the baseline measurement. The average of the differences 
for all subjects were then calculated. There were no significant differences between 
detected changes in FFM or FM when comparing Norland versus iDXA, Norland versus 
BodPod®, or iDXA versus BodPod® (all P>0.05).  
Figure 2 displays the B&A plot results for %BF, FM and FFM for each of the 
three machines compared against each other. Each plot contains both baseline and 
post measurements along with the mean bias and 95% limits of agreement (+1.96 SD). 
In all of the plots the majority of the measurements fall within the limits of agreement 
illustrating that the three machines are in agreement when measuring BF%, FM, and 
FFM.   
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Table 4. Baseline demographic characteristics of the 30 (23 females & 7 males) 
subjects participating in 12-week exercise intervention 
Characteristic Means + SD 
Age (years) 27.56 + 6.7 
Height (cm) 165.48 + 9.12 
Weight (kg) 80.15 + 12.09 
BMI (kg/m2)1 29.17 + 2.96 
%BF2 iDXA 38.95 + 5.77 
FFM3 iDXA (kg) 48.4 + 8.59 
FM4 IDXA (kg) 30.61 + 6.59 
%BF Norland 42.17 + 6.67 
FFM Norland (kg) 48.86 + 9.51 
FM Norland (kg) 35.44 + 7.42 
%BF BodPod® 35.66 + 5.24 
FFM BodPod® (kg) 50.57 + 7.48 
FM BodPod® (kg) 28.37 + 6.86 
1BMI: Body Mass Index  
2%BF: Body Fat Percentage 
3FFM: Fat Free Mass  
4FM: Fat Mass  
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Table 5. Comparison of mean bias, 95% limits of agreement (+1.96 SD), and p-
values for test if bias is different from 0 for body composition parameters 
measured by Norland, iDXA, and BodPod® 
iDXA versus Norland 
Bias Limits of Agreement p-value, Ho: bias is 0
BSL Body Fat % -3.223 (-7.569, 1.123) < 0.001 
BSL Fat Mass -4.834 (-8.443, -1.226) < 0.001 
BSL Lean Mass -0.462 (-4.338, 3.413) 0.844 
POST Body Fat % -2.730 (-7.846, 2.385) < 0.001 
POST Fat Mass -4.655 (-9.405, 0.096) < 0.001 
POST Lean Mass -0.294 (-4.665, 4.077) 0.534 
BodPod® versus Norland 
Bias Limits of Agreement p-value
BSL Body Fat % -6.51 (-14.455, 1.435) < 0.001
BSL Fat Mass -7.068 (-13.475, -0.662) < 0.001
BSL Lean Mass 1.706 (-4.133, 7.546) 0.004
POST Body Fat % -7.914 (-15.927, 0.099) < 0.001
POST Fat Mass -6.910 (-17.506, 3.686) < 0.001
POST Lean Mass 2.867 (-6.570, 12.305) 0.013
BodPod® versus iDXA 
Bias Limits of Agreement p-value
BSL Body Fat % -3.287 (-8.947, 2.374) < 0.001
BSL Fat Mass -2.234 (-6.455, 1.986) < 0.001
BSL Lean Mass 2.169 (-2.821, 7.158) < 0.001
POST Body Fat % -4.968 (-10.793, 0.857) < 0.001
POST Fat Mass -2.268 (-10.129, 5.592) 0.009
POST Lean Mass 2.988 (-3.561, 9.538) 0.001
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Table 6. Comparison of change scores and p-values for baseline and post body 
composition parameters measured by the Norland, iDXA, and BodPod® 
Change Scores 
Mean of 
Differences 
p-value
Fat Mass iDXA minus Norland 0.022 0.949 
Fat Mass Bod Pod minus Norland 0.602 0.628 
Fat Mass Bod Pod minus iDXA 0.376 0.683 
Lean Mass iDXA minus Norland 0.197 0.454 
Lean Mass BodPod® minus Norland 0.809 0.501 
Lean Mass BodPod® minus iDXA 0.562 0.555 
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Figure 2. Plots of each body composition measure compared across the three machines 
before (baseline) and after (post) a 12-week weight loss intervention. Each triangle point 
represents one participant at baseline and each solid point represents one participant at 
post. The upper and lower dashed lines are baseline upper and lower limits of agreement 
and the middle dashed line is the baseline mean bias. Corresponding solid lines are post 
limits of agreement and mean bias.  
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Chapter 5: Discussion 
 
 
 The present study evaluated the agreement between the Norland DXA, the GE 
iDXA, and the BodPod® in a sample of overweight to obese adults before and after a 
12-week exercise intervention. Results indicate the Norland and iDXA similarly assess 
FFM but this is not the case for BF% and FM. The BodPod®’s assessments of FM, 
FFM, and BF% were significantly different than values obtained from both iDXA and 
Norland. The Norland overestimated BF% and FM compared to the iDXA and the 
BodPod® overestimated FFM while underestimating FM compared to both the Norland 
and the iDXA. However, B&A plots indicate that overall the three machines are in 
agreement as at least 93.3% of all values were within limits of agreement for all plots. 
 The overestimation of BF% by the Norland is consistent with previous findings 
from Clark et al. who demonstrated the Norland DXA overestimated BF% in male high 
school wrestlers when compared to BIA, near-infrared photospectometry (NIR), and 
anthropometry [36]. In the present study, the overestimation of BF% compared to the 
iDXA can be explained by the overestimation of FM, as measures of FFM were not 
different.  
 Model type could be one explanation for the differences discovered between 
iDXA and Norland. The two most common types of DXA technologies are pencil and fan 
beam. Pencil beam provides an orthogonal projection on a single detector while fan 
beam projected a magnified image on an array of multiple detectors [37]. Specifically, 
the iDXA has a high-definition, narrow-angle fan beam with multi-view image 
reconstruction along with a direct-to-digital detector with a staggered array. Conversely, 
the Norland uses a pencil beam scanner. The detectors of the two machines also 
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function in different ways. The iDXA has a dose-efficient photon counting detector that 
simultaneously counts low and high-energy x-ray photons as it is scanning, using a 
constant flux fixed for the entire scan. The Norland has two detectors, one dedicated to 
low energy and one to high energy, but varies flux dynamically [38]. Others have argued 
that pencil beam and fan beam systems shouldn’t be used interchangeably especially 
for longitudinal studies, because of these differences [39]. Other findings suggest %BF 
between pencil and fan beam systems are highly correlated, but vary by system [40]. 
Litaker et al. reported fan beam scanners tended to give greater measurements of FM 
among leaner individuals and the pencil-beam gives greater measures than the fan 
beam for those with greater FM [41]. This matches the present study findings since all 
of the participants were either overweight or obese.  
 Another difference between the two machines is the size of the scan table. 
Historically the scan tables were designed to fit in a small 8’x8’ room since the main 
purpose was intended to be for bone density measurements of the spine and hip. Once 
the DXA started being used for other measures patients being too tall or wide to 
completely fit on the table became problematic. The Norland Elite was created 
specifically for larger populations. It can scan individuals up to 625 lbs (283.5 kg), 54” 
(137 cm) wide, and 7’6” (228cm) tall [9]. The iDXA has a weight limit of 450 lbs (205kg) 
and has a scan window of only 37” (94 cm) wide and 6’7”(196cm) in length [33]. This 
could potentially impact the assessment of FM, if the machine has to rely on a half body 
scan (due to the subject not completely fitting on the table). Although half-body scans 
have been found to be closely comparable to full body scans on the iDXA [42]. The 
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current study did not use half-body scans on any participants, so differences in scan 
table size may not have played a role in the current results.  
There was no significant bias for FFM estimates between the Norland and the 
iDXA. This agrees with previous findings by Ioannidou et al., which found no significant 
bias in appendicular lean soft tissue between two pencil-beam scanners (Lunar DPX 
and DPX-L) and two fan-beam scanners (Lunar Prodigy and Hologic Dephi A) [43]. This 
raises the question why the two DXAs would be similar for FFM but different for FM. 
One explanation is that DXA technology has a more difficult time determining FM than 
FFM because FM is a lighter attenuator than FFM. This causes the system to work at 
the edge of its optimal range and register fat with more error [37].  
The differences between the BodPod® and both the iDXA and Norland DXA 
agrees with previous research demonstrating DXA and ADP produce significantly 
different BF% measurements [44]. Ferris-Moralas et al. also found discrepancies 
between DXA and BodPod® but reported DXA underestimated BF% compared to ADP 
in a group of young male athletes [45], which is not in agreement with the present study, 
although differences in study population could be a factor. Differences in DXA outcomes 
compared with the 4C model have been associated with increased tissue thickness, the 
thicker the tissue the greater degree of beam hardening which involves the lower 
energy x-rays becoming more easily attenuated or even completely absorbed [46], 
which may have occurred in our sample. 
It is important to note the BodPod® measurements were taken while the 
participant was fasted and on a separate day than the DXA scans. These factors could 
explain some variation in the measurements from the BodPod® compared to the two 
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DXA scans. The DXA scans were completed back to back within the same hour on the 
same day and, therefore, factors such as hydration status should not have played a 
role.  
All three machines were equally precise when measuring longitudinal changes. 
In other words, the differences between the machines observed at baseline were also 
observed at post-intervention as none of the change scores between the machines 
were different from zero. Weyers et al. reported a similar finding in which DXA and 
BodPod® measured similar absolute changes in %BF, FM, and FFM after weight loss 
[27]. Sasai et al also found that ADP was comparable to DXA for evaluating change in 
BF% [47]. Tracking the assessment of changes overtime may be more relevant in some 
circumstances than the exact BF% of individuals, since exact body composition cannot 
truly be determined. Utilizing any three of these machines will provide more information 
regarding individual changes and effectiveness of weight loss interventions or athletic 
training programs than just using an individual’s weight.  
The B&A plots were all in agreement defined as +/- 1.96 SD, although these 
limits of agreement (LOA) are very wide. For example, the LOA for iDXA compared to 
the Norland for FM spanned over 8 kg (17.6 lbs), which is an excessively large clinical 
difference. Over or underestimating FM by this large of a margin would likely lead to an 
inaccurate health assessment, thus the B&A limits of agreement are likely not the best 
criteria to use in the present evaluation.  
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Conclusion 
The present study’s findings fill the gap in knowledge regarding the Norland DXA. 
No previous studies have compared the Norland Elite DXA to the iDXA or to the 
BodPod®. As newer versions of DXA are created, such as the Norland Elite, it is 
imperative to understand their accuracy compared to the better-researched machines 
such as the iDXA and precision over time. The Norland’s larger scan table could benefit 
a variety of populations such as the bariatric surgery patients and athletes; however the 
current findings suggest the Norland and iDXA produce different estimates of FM, while 
FFM is consistent between the devices. Therefore, the Norland and iDXA should not be 
used interchangeably for BF% and FM estimates. Measurements from the BodPod® 
should also not be used interchangeably with either DXA machine for FM or FFM.  
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